Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demons

Novavax COVID-19 Data Presented at FDA VRBPAC Meeting Demonstrates Broad Antibody Responses to Both Prototype and Omicron-Specific Variants

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious...

Related Keywords

Mexico , United States , India , Gregorym Glenn , Ali Chartan , Department Of Defense , National Institute Of Allergy , Prnewswire Novavax Inc , Advisory Committee , Nasdaq , Serum Institute , Novavax Inc , National Institutes Of Health , Biomedical Advanced Research , Human Services , Us Department Of Health , Drug Administration , European Commission , World Health Organization , Development Authority , Exchange Commission , Office Of The , Products Advisory Committee , Novavax Omicron , Related Biological Products Advisory Committee , Emergency Use Authorization , Vaccine Efficacy Novavax Trial , New England Journal , Assistant Secretary , National Institute , Infectious Diseases , National Institutes , World Health , Financial Condition , Novavax Annual Report , Quarterly Reports , Novavax , Nc ,